Molecular Assemblies: Funding, Investors & Team (Sep 2026)
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.
Molecular Assemblies has raised $41.9M across 4 funding rounds on record, the most recent an undisclosed round of $4.0M announced in Aug 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Molecular Assemblies Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Molecular Assemblies Funding Rounds
Molecular Assemblies raised $11.8M in a Series A announced in Apr 2021.
6 months later, a Grant of $300k was announced in Oct 2021.
5 months later, a Series B of $25.8M was announced in Mar 2022.
2.4 years later, an undisclosed round of $4.0M was announced in Aug 2024.
Molecular Assemblies Founders and Leadership Team
No contact details are on record for this team yet.
Molecular Assemblies Funding Compared to Other Biotechnology Startups
Molecular Assemblies' latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Molecular Assemblies in Biotechnology and San Diego
Companies Similar to Molecular Assemblies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Molecular Assemblies Funding FAQs
What does Molecular Assemblies do?
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.
How much funding has Molecular Assemblies raised?
Molecular Assemblies has raised $41.9M across 4 rounds on record. The most recent is an undisclosed round of $4.0M announced in Aug 2024.
When did Molecular Assemblies last raise funding?
Molecular Assemblies' most recent funding round on record is an undisclosed round of $4.0M, announced in Aug 2024.
Who founded Molecular Assemblies?
FundedIQ lists William Efcavitch (Founder) at Molecular Assemblies.
Who is the CEO of Molecular Assemblies?
Michael Kamdar is listed as CEO at Molecular Assemblies.
Where is Molecular Assemblies headquartered?
Molecular Assemblies is based in San Diego, California, United States.
How many employees does Molecular Assemblies have?
Molecular Assemblies is in the 11-50 employee band.
How does Molecular Assemblies' funding compare to other Biotechnology startups?
Molecular Assemblies' latest round of $4.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Molecular Assemblies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Molecular Assemblies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.